A single pill for heart attack recovery
Part of Heart & circulation clinical trials.
This study tests a single pill that combines three heart medicines—aspirin, a blood thinner, and a statin—to see if it helps people who have had a heart attack or stent procedure. It aims to make it easier to take your daily heart medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You were in the hospital for a heart attack or unstable angina and had a stent placed.
- You are currently taking aspirin, a blood thinner (prasugrel or clopidogrel), and a high-dose statin.
- You are not taking a stronger blood thinner (like warfarin) for a condition like atrial fibrillation or a blood clot.
- You have no known allergies to aspirin, prasugrel, clopidogrel, or rosuvastatin (Crestor).
- You are not pregnant and do not have a condition that might limit your life to less than 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether changing the timing and type of blood-thinner tablets after a heart stent is as safe and effective as continuing the same plan. It may help some people by simplifying treatment while preventing dangerous clotting after a coronary procedure.
This study tests whether a personalized score (OPT-CAD) can help decide the best time to stop or reduce blood-thinning medication in people who have had a heart attack and a stent placed. It aims to balance preventing future heart issues while lowering the risk of bleeding.
This trial looks at how a daily “polypill” affects coronary (heart blood vessel) risk factors in adults who already take this polypill for prevention after a prior heart event. If you’re eligible, you’ll complete several study visits so the team can compare risk factors over time.
This Phase 3 trial tests whether a daily “polypill” can reduce the chance of another stroke after a recent ischemic stroke. It may help people by improving several heart-and-blood-vessel risks at once, but only if it fits safely with their medical situation.
This trial studies whether a specific stent (with no polymer coating) plus a single blood thinner plan with aspirin and another P2Y12 medicine is as safe and effective as the standard two-medicine plan after a STEMI heart attack. It may help people avoid longer exposure to stronger blood-thinning if the new approach works as well.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.